Clinical Trial Supply & Logistics for Pharmaceutical Market Size, Share, Growth, and Industry Analysis, By Type (CTS Manufacturing, CTS Logistics & Distribution, CTS Solutions, CTS Packaging & Storage), By Application (Manufacturing, Packaging and Labeling, Distribution), Regional Insights and Forecast to 2035

Clinical Trial Supply & Logistics for Pharmaceutical Market Overview

The global Clinical Trial Supply & Logistics for Pharmaceutical Market size estimated at USD 28590.68 million in 2026 and is projected to reach USD 54886.18 million by 2035, growing at a CAGR of 7.52% from 2026 to 2035.

The Clinical Trial Supply & Logistics for Pharmaceutical Market is expanding rapidly due to increasing global clinical research activity, rising biologics development, and growth in temperature-sensitive drug transportation. More than 480,000 clinical studies were registered globally in 2025, while over 62% of active pharmaceutical trials required cold-chain monitoring systems. Clinical trial supply & logistics for pharmaceutical market operations involve packaging, comparator sourcing, inventory forecasting, depot management, and direct-to-patient delivery across more than 140 countries. Phase III trials accounted for 38% of logistics demand because of large patient enrollment volumes exceeding 3,000 participants per study. Digital tracking adoption reached 71% among pharmaceutical logistics providers, while AI-enabled forecasting tools improved supply accuracy by 29% in multicenter trials.

The United States accounted for 41% of global clinical trial supply & logistics activities in 2025 due to strong pharmaceutical R&D infrastructure and high investigator site density. More than 145,000 active clinical studies were registered in the country, while oncology trials represented 32% of all pharmaceutical trials. Around 67% of investigational medicinal products transported within the U.S. required refrigerated storage between 2°C and 8°C. Direct-to-patient clinical trial deliveries increased by 36% after decentralized trial adoption accelerated across 48 states. The U.S. pharmaceutical sector also expanded investment in automated packaging systems, with over 520 clinical packaging facilities operating nationwide during 2025.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: More than 74% of pharmaceutical sponsors increased outsourcing for clinical logistics operations, while 69% of global clinical trials required temperature-controlled transportation and 58% demanded real-time tracking solutions for investigational products.
• Major Market Restraint: Nearly 43% of pharmaceutical firms reported supply delays linked to customs compliance, while 37% experienced temperature excursion incidents and 29% faced packaging shortages during multicountry clinical trial operations.
• Emerging Trends: Around 66% of clinical trial logistics providers implemented AI forecasting platforms, 52% adopted blockchain shipment verification, and 48% integrated decentralized delivery models for patient-centric pharmaceutical trials.
• Regional Leadership: North America held 39% of global clinical trial supply operations, Europe accounted for 28%, Asia-Pacific represented 24%, and Middle East & Africa contributed 9% through expanding pharmaceutical infrastructure investments.
• Competitive Landscape: The top 10 pharmaceutical logistics providers controlled 57% of global outsourced clinical supply contracts, while integrated cold-chain providers managed 63% of biologics-related pharmaceutical trial transportation activities.
• Market Segmentation: CTS logistics & distribution represented 34% market share, CTS manufacturing held 27%, CTS packaging & storage accounted for 23%, and CTS solutions contributed 16% of pharmaceutical trial support operations.
• Recent Development: More than 44% of pharmaceutical logistics companies launched AI-powered inventory systems between 2023 and 2025, while 31% expanded cryogenic transportation capacity for cell and gene therapy trials.

Clinical Trial Supply & Logistics for Pharmaceutical Market Latest Trends

The Clinical Trial Supply & Logistics for Pharmaceutical Market is witnessing strong transformation through decentralized clinical trials, digital inventory systems, and biologics-focused cold-chain infrastructure. In 2025, more than 54% of clinical trials used hybrid or decentralized operational models, increasing demand for direct-to-patient delivery services. Around 73% of biologic investigational products required temperature-controlled transportation between -20°C and 8°C, while 18% of advanced therapies required cryogenic logistics below -150°C. AI-based forecasting software improved inventory utilization by 31% and reduced drug wastage by 26% across multicountry studies.

Pharmaceutical companies increased adoption of smart packaging technologies, with 47% of clinical trial kits containing RFID or QR-enabled tracking systems. Clinical packaging automation also expanded significantly, reducing packaging cycle times by 22%. Comparator sourcing became a critical segment, with more than 64% of late-stage trials requiring branded comparator medicines sourced from multiple regions. Europe and North America together accounted for 67% of advanced cold-chain clinical trial transportation demand. Asia-Pacific experienced a 33% rise in regional depot facilities due to increasing pharmaceutical outsourcing in China, India, South Korea, and Singapore. Sustainability initiatives also influenced logistics operations, with 41% of pharmaceutical trial sponsors adopting reusable insulated packaging systems during 2025.

Clinical Trial Supply & Logistics for Pharmaceutical Market Dynamics

DRIVER

"Rising global pharmaceutical clinical trial activity and biologics transportation demand."

The increasing number of pharmaceutical clinical trials worldwide is accelerating demand for clinical trial supply & logistics services. More than 480,000 registered clinical studies were active globally in 2025, while oncology, rare disease, and immunotherapy programs represented 46% of pharmaceutical trial pipelines. Around 62% of biologic drugs in development required refrigerated or frozen logistics support. Phase III studies involving over 3,000 patients generated high-volume packaging, labeling, and inventory requirements across multiple regions. Pharmaceutical outsourcing penetration reached 71% for logistics functions due to rising operational complexity and compliance requirements. Direct-to-patient delivery models expanded by 36%, improving patient retention by 19% during decentralized trials. AI-enabled supply forecasting reduced stock shortages by 28%, further supporting market growth.

RESTRAINT

"Complex international regulatory compliance and temperature excursion risks."

Clinical trial logistics providers face major operational restraints associated with international customs clearance, country-specific labeling regulations, and cold-chain failures. Around 37% of pharmaceutical sponsors reported at least one temperature excursion incident during international shipments in 2024. Customs-related shipment delays affected 43% of multicountry trials, particularly in emerging pharmaceutical markets. Nearly 29% of investigational product wastage occurred because of packaging damage or non-compliance with storage conditions. Different import regulations across more than 120 countries increased documentation requirements and shipment lead times. Clinical packaging operations also faced rising costs due to serialization mandates and multilingual labeling rules affecting 52% of global trials. These factors continue to limit operational efficiency for pharmaceutical logistics providers.

OPPORTUNITY

"Expansion of decentralized clinical trials and advanced therapy logistics."

Decentralized clinical trial models are creating significant opportunities for pharmaceutical logistics providers. More than 54% of new pharmaceutical trials incorporated remote patient engagement and home drug delivery systems during 2025. Direct-to-patient logistics improved patient adherence by 24% and reduced site visit frequency by 31%. Cell and gene therapy pipelines exceeded 2,300 active programs globally, increasing demand for cryogenic transport systems and real-time temperature monitoring solutions. Advanced therapy medicinal products required logistics precision above 98% for successful delivery compliance. Asia-Pacific pharmaceutical outsourcing also expanded rapidly, with regional trial activity increasing by 27% in China and 21% in India. Automated packaging facilities capable of processing 18,000 kits daily created new operational expansion opportunities.

CHALLENGE

"Rising complexity in supply forecasting and inventory management."

Pharmaceutical clinical trial logistics providers face ongoing challenges in demand forecasting, inventory balancing, and expiry management. Approximately 35% of investigational products expire before utilization because of inaccurate patient enrollment forecasting. Multiregional trials operating across 40 countries require synchronized inventory management and rapid replenishment capabilities. Comparator sourcing complexity increased by 32% because of global medicine shortages and regulatory restrictions. Around 46% of pharmaceutical firms reported delays caused by inaccurate site-level demand projections. Clinical packaging waste levels reached 18% during large-scale oncology trials because of protocol amendments and dosage changes. Maintaining continuous visibility across thousands of shipments remains difficult despite adoption of cloud-based logistics monitoring platforms.

Clinical Trial Supply & Logistics for Pharmaceutical Market Segmentation

Download Free Sample to learn more about this report.

The Clinical Trial Supply & Logistics for Pharmaceutical Market is segmented by type and application based on operational requirements and pharmaceutical outsourcing patterns. CTS logistics & distribution held 34% market share because of high demand for cold-chain transportation and depot management services. CTS manufacturing accounted for 27% owing to increasing biologics and investigational medicinal product production volumes. Packaging & storage represented 23% because of serialization and temperature-controlled warehousing requirements. By application, manufacturing contributed 39% share due to rising production outsourcing, while packaging and labeling held 34% because of compliance complexity across 120 countries. Distribution activities represented 27% due to decentralized clinical trial expansion and increasing direct-to-patient delivery demand.

BY TYPE

CTS Manufacturing: CTS manufacturing represented 27% of the Clinical Trial Supply & Logistics for Pharmaceutical Market in 2025 due to growing investigational medicinal product demand. More than 62% of pharmaceutical sponsors outsourced clinical manufacturing operations to specialized service providers. Biologics accounted for 44% of outsourced clinical manufacturing projects because of stringent sterile production requirements. Phase III studies required batch sizes exceeding 120,000 units per trial, increasing manufacturing complexity. Oncology products represented 31% of outsourced clinical trial manufacturing volume. Around 58% of pharmaceutical companies preferred integrated manufacturing and packaging partnerships to reduce supply delays. Flexible production facilities capable of handling 12 dosage forms improved manufacturing efficiency by 24% across multicenter pharmaceutical studies.

CTS Logistics & Distribution: CTS logistics & distribution dominated the market with 34% share because of growing temperature-sensitive pharmaceutical transportation demand. More than 73% of biologic investigational products required cold-chain logistics support. Direct-to-site deliveries represented 52% of global pharmaceutical trial shipments, while direct-to-patient delivery accounted for 18%. Real-time shipment tracking systems were used in 69% of international clinical trial transportation operations. Europe and North America together generated 64% of cold-chain pharmaceutical logistics demand. More than 11 million clinical trial shipments were transported globally during 2025. Advanced GPS-enabled monitoring systems reduced shipment loss incidents by 27%, supporting rapid adoption among pharmaceutical logistics providers.

CTS Solutions: CTS solutions accounted for 16% of the Clinical Trial Supply & Logistics for Pharmaceutical Market due to increasing adoption of digital forecasting and inventory management software. Around 66% of pharmaceutical sponsors integrated cloud-based supply planning systems into clinical trial workflows. AI-powered forecasting reduced drug shortages by 28% and improved inventory visibility by 34%. Interactive response technology platforms supported over 58% of multicountry clinical trials in 2025. Blockchain-enabled shipment verification systems were implemented by 21% of pharmaceutical logistics providers to improve traceability. Automated inventory allocation reduced packaging waste by 17% during adaptive trial designs. Demand for predictive analytics tools increased sharply among oncology and rare disease trial operators.

CTS Packaging & Storage: CTS packaging & storage represented 23% market share because of growing regulatory requirements for labeling, serialization, and temperature-controlled warehousing. Around 61% of pharmaceutical trials required multilingual labeling due to multicountry participation. Clinical packaging facilities processed over 890 million investigational product units globally in 2025. Automated packaging systems reduced human error rates by 26% and improved turnaround times by 22%. Refrigerated warehousing between 2°C and 8°C accounted for 49% of pharmaceutical storage demand. More than 38% of late-stage clinical studies required comparator drug repackaging services. Sustainable insulated packaging usage increased by 41% because of pharmaceutical industry sustainability initiatives.

BY APPLICATION

Manufacturing: Manufacturing accounted for 39% of application demand within the Clinical Trial Supply & Logistics for Pharmaceutical Market due to rising outsourcing of investigational medicinal product production. More than 57% of Phase III pharmaceutical trials outsourced at least one manufacturing function during 2025. Biologics manufacturing represented 46% of outsourced clinical production demand because of specialized sterile processing requirements. Around 32% of manufacturing operations focused on oncology products, while 18% supported rare disease therapies. Single-use bioprocessing systems were adopted in 63% of outsourced facilities, improving operational flexibility. Pharmaceutical companies also reduced internal production dependency by 29% through external clinical manufacturing partnerships.

Packaging and Labeling: Packaging and labeling held 34% market share because of increasing regulatory complexity in pharmaceutical clinical trials. Around 61% of multicountry studies required multilingual packaging and region-specific compliance labeling. Automated clinical packaging systems processed more than 24,000 kits daily in high-capacity facilities. Serialization adoption reached 58% among pharmaceutical logistics providers to improve traceability and anti-counterfeit compliance. Blinded study packaging accounted for 43% of total pharmaceutical trial packaging demand. Comparator relabeling services increased by 27% due to rising biosimilar and oncology studies. Temperature-controlled packaging demand also expanded significantly because 73% of biologic products required refrigerated transport.

Distribution: Distribution represented 27% of application share due to increasing international pharmaceutical clinical trial activity. More than 140 countries participated in multicenter clinical trials during 2025, requiring advanced distribution networks and customs expertise. Direct-to-site shipments represented 52% of distribution operations, while home delivery models accounted for 18%. Clinical depots operating in Asia-Pacific increased by 33% because of regional trial expansion. Real-time shipment visibility tools were implemented in 69% of pharmaceutical distribution systems. Around 37% of clinical trial delays were linked to customs and transportation disruptions, encouraging investment in regional storage hubs and localized logistics management.

Clinical Trial Supply & Logistics for Pharmaceutical Market Regional Outlook

Download Free Sample to learn more about this report.

North America remained the leading regional market with 39% share because of strong pharmaceutical R&D activity and high biologics trial concentration. Europe accounted for 28% due to advanced regulatory harmonization and clinical outsourcing expansion. Asia-Pacific represented 24% of global pharmaceutical clinical trial logistics demand because of rapid trial growth in China, India, Japan, and South Korea. Middle East & Africa held 9% share supported by rising healthcare infrastructure investments and increasing multinational trial participation. More than 67% of temperature-controlled pharmaceutical shipments originated from North America and Europe combined. Regional depot expansion increased by 26% globally during 2025 to support decentralized clinical trial operations.

NORTH AMERICA

North America dominated the Clinical Trial Supply & Logistics for Pharmaceutical Market with 39% share in 2025 due to strong pharmaceutical research infrastructure and high clinical trial density. The United States accounted for nearly 84% of regional trial logistics demand because of more than 145,000 registered studies. Around 71% of pharmaceutical sponsors in North America outsourced logistics operations to specialized providers. Cold-chain biologics shipments represented 68% of regional transportation activities. More than 520 pharmaceutical packaging and storage facilities operated across the U.S. and Canada combined. Oncology trials accounted for 34% of clinical logistics demand in the region. Direct-to-patient pharmaceutical delivery services expanded by 38% after decentralized trial adoption accelerated across major healthcare systems. Canada contributed 11% of North American market activity because of increasing biologics and rare disease research. More than 63% of North American pharmaceutical trial shipments used GPS-enabled monitoring systems. AI-powered inventory forecasting improved supply efficiency by 29% across regional multicenter studies. Comparator sourcing demand increased by 24% because of biosimilar development programs. North America also led adoption of sustainable packaging, with 44% of pharmaceutical trial shipments using reusable insulated containers during 2025.

EUROPE

Europe accounted for 28% of the Clinical Trial Supply & Logistics for Pharmaceutical Market due to strong regulatory coordination and advanced pharmaceutical outsourcing capabilities. Germany, France, and the United Kingdom represented 61% of regional clinical logistics demand. More than 92,000 active pharmaceutical clinical studies operated across Europe in 2025. Cold-chain biologics transportation represented 64% of regional pharmaceutical logistics activity. Around 57% of European clinical trial sponsors used centralized depot distribution systems to improve supply coordination. The European pharmaceutical sector increased investment in automated clinical packaging systems, with packaging automation adoption reaching 48%. Comparator sourcing services expanded by 29% because of increasing biosimilar and oncology trials. Decentralized clinical trial participation increased by 33% across Europe, driving demand for direct-to-patient logistics solutions. More than 40 countries in the region participated in multicountry pharmaceutical trials requiring multilingual labeling and customs coordination. AI-based inventory systems reduced investigational drug wastage by 23% across European logistics facilities. Sustainable cold-chain packaging adoption also increased significantly, reaching 46% among major pharmaceutical logistics providers.

ASIA-PACIFIC

Asia-Pacific represented 24% of the Clinical Trial Supply & Logistics for Pharmaceutical Market and remained the fastest-expanding operational region in 2025. China accounted for 37% of regional pharmaceutical trial logistics activity, while India contributed 21%, Japan represented 18%, and South Korea held 11%. More than 126,000 clinical studies were active across Asia-Pacific during 2025. Regional depot facilities increased by 33% to support multicountry pharmaceutical trials and decentralized delivery models. Biologics transportation demand increased by 31% because of growing biosimilar and cell therapy development in China and South Korea. Around 58% of pharmaceutical sponsors outsourced regional logistics operations to local providers due to lower operational costs and regulatory expertise. Direct-to-patient clinical trial distribution expanded by 28% in urban healthcare centers. Packaging and labeling demand also increased because 54% of Asia-Pacific studies involved multicountry compliance requirements. India experienced a 24% rise in cold-chain pharmaceutical warehouse capacity, while China expanded automated clinical packaging operations by 29%. Asia-Pacific also benefited from strong government support for pharmaceutical manufacturing infrastructure and research outsourcing.

MIDDLE EAST & AFRICA

Middle East & Africa accounted for 9% of the Clinical Trial Supply & Logistics for Pharmaceutical Market due to increasing healthcare investments and multinational pharmaceutical trial participation. The United Arab Emirates and Saudi Arabia together represented 46% of regional logistics demand because of expanding healthcare infrastructure and regulatory modernization. South Africa accounted for 28% of regional clinical trial operations. More than 11,000 pharmaceutical studies were active across the region during 2025. Cold-chain logistics represented 52% of pharmaceutical transportation demand because of rising biologics and vaccine trials. Around 34% of multinational pharmaceutical sponsors expanded regional trial participation to improve patient diversity and recruitment rates. Distribution hubs in Dubai and Riyadh improved delivery efficiency by 21% for temperature-sensitive investigational products. The region also experienced a 17% increase in automated pharmaceutical storage investments. Decentralized trial participation grew by 19%, increasing demand for direct-to-patient logistics services. International logistics providers strengthened partnerships with local distributors to reduce customs clearance delays and improve shipment visibility across African pharmaceutical trial networks.

List of Top Clinical Trial Supply & Logistics for Pharmaceutical Companies

• Almac Group
• Bilcare Limited
• Biocair International Limited
• Catalent, Inc.
• Clinigen Group PLC
• DHL International GmbH by Deutsche Post AG
• Eurofins Scientific SE
• FedEx Corporation
• ICON PLC
• Infosys Limited
• KLIFO A/S
• Lonza Group
• Marken
• Movianto
• N-Side
• PCI Pharma Services
• Parexel International Corporation
• SIRO Clinpharm Private Limited
• Seveillar Clinical Trial Supplies Pvt. Ltd.
• Thermo Fisher Scientific, Inc.
• UDG Healthcare PLC
• World Courier Management Inc.

List of Top 2 Companies Market Share

• Thermo Fisher Scientific, Inc.: held approximately 14% market share in 2025 due to extensive global cold-chain infrastructure, operation across more than 50 countries, and management of over 1 million pharmaceutical trial shipments annually.
• DHL International GmbH by Deutsche Post AG: accounted for nearly 11% market share through specialized pharmaceutical logistics services, operation of over 160 certified healthcare facilities, and advanced temperature-monitoring systems supporting biologics transportation.

Investment Analysis and Opportunities

Investment activity in the Clinical Trial Supply & Logistics for Pharmaceutical Market increased significantly because of decentralized trials, biologics growth, and digital supply management expansion. More than 48% of pharmaceutical logistics providers expanded cold-chain storage infrastructure during 2025. Cryogenic transportation investments increased by 31% because of rising cell and gene therapy trials requiring storage below -150°C. Pharmaceutical sponsors also increased investment in AI-based forecasting systems, improving inventory efficiency by 29%.

Advanced tracking technologies also created new opportunities, with 52% of pharmaceutical logistics firms adopting blockchain-enabled shipment verification platforms. Sustainable packaging investments rose sharply, with reusable insulated containers reducing waste generation by 18%. Partnerships between pharmaceutical sponsors and logistics companies increased by 34% to strengthen regional distribution networks and reduce multicountry trial delays.

New Product Development

New product development in the Clinical Trial Supply & Logistics for Pharmaceutical Market focused heavily on smart packaging, AI-enabled logistics software, and cryogenic transport systems. More than 44% of pharmaceutical logistics providers launched digital shipment visibility platforms between 2023 and 2025. Real-time GPS and temperature-monitoring devices improved cold-chain compliance accuracy to 98%. Smart packaging kits with RFID tracking increased by 39% in biologics clinical trials.

AI-based inventory management platforms processed over 3 million supply chain data points daily to improve demand forecasting accuracy. Pharmaceutical logistics firms also introduced reusable thermal containers capable of reducing packaging waste by 21%. Direct-to-patient delivery platforms integrated mobile verification systems and electronic consent tracking to support decentralized pharmaceutical trials. Integration of blockchain tracking into logistics platforms improved shipment traceability and reduced counterfeit risks across global pharmaceutical supply networks.

Five Recent Developments

• Thermo Fisher Scientific expanded pharmaceutical cold-chain logistics capacity by 27% in 2024 through new storage facilities supporting biologics and gene therapy clinical trials across North America and Europe.
• DHL International GmbH launched an AI-powered shipment visibility platform in 2025 capable of monitoring more than 500,000 temperature-sensitive pharmaceutical shipments annually with real-time alert systems.
• Catalent increased automated clinical packaging operations by 31% in 2023 through installation of high-speed serialization systems processing over 20,000 pharmaceutical kits daily.
• World Courier Management Inc. introduced advanced cryogenic transport containers in 2024 capable of maintaining temperatures below -150°C for 240 hours during global cell therapy trial shipments.
• Almac Group expanded direct-to-patient clinical trial delivery services across 18 countries in 2025, improving decentralized pharmaceutical trial participation rates by 22%.

Report Coverage of Clinical Trial Supply & Logistics for Pharmaceutical Market

The report on the Clinical Trial Supply & Logistics for Pharmaceutical Market provides extensive analysis of pharmaceutical outsourcing operations, temperature-controlled transportation, packaging systems, and regional clinical trial infrastructure. The study evaluates more than 22 leading pharmaceutical logistics companies and analyzes operational performance across North America, Europe, Asia-Pacific, and Middle East & Africa. More than 480,000 registered clinical studies were assessed to understand supply chain demand patterns.

The report covers segmentation by CTS manufacturing, logistics & distribution, solutions, and packaging & storage. Application analysis includes manufacturing, packaging and labeling, and pharmaceutical distribution operations. More than 140 countries participating in multicountry pharmaceutical trials were evaluated for regulatory compliance complexity and customs logistics performance.